WT
ONC

Washington Trust’s BeOne Medicines Ltd ONC Stock Holding History

Washington Trust’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10
Closed -$2.72K – 764
2025
Q1 		$2.72K Hold
10
– – ﹤0.01% 702
2024
Q4 		$1.85K Hold
10
– – ﹤0.01% 809
2024
Q3 		$2.25K Sell
10
-8
-44% -$1.44K ﹤0.01% 795
2024
Q2 		$2.57K Buy
18
+2
+13% +$308 ﹤0.01% 803
2024
Q1 		$2.5K Buy
16
+6
+60% +$966 ﹤0.01% 802
2023
Q4 		$1.8K Buy
+10
New +$1.81K ﹤0.01% 791

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Washington Trust's ONC Position: Q2 2025 in Review

Washington Trust sold out of BeOne Medicines Ltd (ONC) in Q2 2025, closing a stake of 10 shares — an estimated $2.72K sold.

Washington Trust first reported a position in ONC in Q4 2023 and held it in 6 quarters. The position peaked at $2.72K in Q1 2025. 244 funds tracked by Wall St. Rank hold ONC as of Q2 2025.

  • Washington Trust reported no remaining BeOne Medicines Ltd position as of Q2 2025 after selling out during the quarter.
  • Washington Trust sold 10 BeOne Medicines Ltd shares in Q2 2025, an estimated $2.72K.
  • Washington Trust first reported a position in BeOne Medicines Ltd in Q4 2023 and held it in 6 quarters.
  • Washington Trust's BeOne Medicines Ltd position peaked at $2.72K in Q1 2025.
  • 244 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2025.

Based on Washington Trust's 13F filing for Q2 2025, filed 8 Aug 2025.